At the news
? BULLISHIMPACT 8/10 8-K filed Feb 26, 2026 at 07:05 ET
Phathom Pharmaceuticals reported strong financial results for Q4 and full year 2025, with revenue of $57.6 million in Q4 and $175.1 million for the full year, representing a 217% increase from 2024. The company also announced $130 million in gross proceeds from an equity offering and provided 2026 guidance with expected operating profitability beginning in Q3 2026.
- Q4 2025 revenue was $57.6 million, up from $29.7 million in Q4 2024
- Full year 2025 revenue was $175.1 million, a 217% increase from $55.3 million in 2024
- Company completed $130 million equity offering in January 2026
- Provided 2026 guidance with net revenues of $320-345 million and expected operating profitability beginning in Q3 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access